Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
With appropriate clinical trials, this gastric pentadecapeptide may ultimately provide clinically valuable applications for conditions currently lacking optimal treatment options
9 , e1003774 (2013)
by the National Institute of General Medical Sciences of the National Institutes of Health under award number DP2GM132931
From an expert perspective, these smart nanoplatforms demonstrate strong adaptability and efficacy in responding to the tumor microenvironment and external stimuli, effectively addressing the drawbacks of traditional treatments, which are prone to drug resistance
US$ 22.35
US$ 23.95
US$ 26.53
US$ 24.15
